Revvity | PKI - Ebitda


Revvity reported $228.18M in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Agilent USD 456M 84M Dec/2025
Align Technology USD 229.14M 31.74M Mar/2026
Bio Techne USD 116.71M 13.29M Mar/2026
Bio-Rad Laboratories USD -636.6M 1.62B Mar/2026
Bruker USD 143.2M 33.2M Jun/2026
Celltrion KRW 19.64B 1.85B Mar/2026
Charles River Laboratories USD 229.8M 28.26M Mar/2026
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Danaher USD 1.84B 81M Jun/2026
Dentsply International USD 129M 6M Mar/2026
Deva Holding AS TRY 882.9M 201.7M Sep/2023
Dianthus Therapeutics USD -46.46M 6.27M Mar/2026
Divis Laboratories Ltd INR 12.62B 3.28B Jun/2026
Edwards Lifesciences USD 555.6M 485.5M Mar/2026
Illumina USD 330M 80M Jun/2026
Intuitive Surgical USD 1.06B 29.9M Mar/2026
IQVIA Holdings USD 994M 62M Jun/2026
Kangmei Pharma CNY -12.72M 30.02M Mar/2026
Knight Therapeutics CAD 24.45M 3.46M Dec/2025
Laboratorios Farma EUR 34.94M 102.95M Jun/2025
Laboratory Of America USD 767.7M 162.1M Jun/2026
Malin Corporation EUR -1.1M 200K Dec/2024
Medical Developments International AUD 1.78M 3.78M Dec/2024
Mesa Laboratories USD 9.58M 1.47M Sep/2024
Mettler Toledo International USD 322.64M 43.66M Jun/2026
Myriad Genetics USD 14.3M 4M Dec/2025
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025
OraSure Technologies USD -17.7M 4.06M Dec/2025
Organigram Holdings CAD -4.76M 10.02M Mar/2026
Pacific Biosciences Of California USD -35.4M 5.78M Sep/2025
Pharma Mar EUR 700K 2.01M Jun/2026
Qiagen NV USD 148.09M 101.6M Mar/2026
Quest Diagnostics USD 648M 91M Jun/2026
Quidel USD 108.7M 44.6M Mar/2026
Repligen USD 43.77M 3.76M Jun/2026
Revvity USD 228.18M 44.73M Jun/2026
Sartorius EUR 280.5M 13.2M Jun/2026
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
Thermo Fisher Scientific USD 3.55B 845M Jun/2026
Tilray USD 8.36M 1.82M Sep/2025
Waters USD 712M 545M Jun/2026
Zealand Pharma A/S -379M 348.47M Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M Mar/2026